Clinical Immunology Service

Organisational unit: Department

Publications

  1. Published

    What is the significance of monoclonal gammopathy of undetermined significance?

    Catherine Atkin, Alex Richter & Elizabeth Sapey, Oct 2018, In: Clinical Medicine. 18, 5, p. 391-396 6 p.

    Research output: Contribution to journalReview articlepeer-review

  2. E-pub ahead of print
  3. Published
  4. Published
  5. Published

    Understanding COVID-19: are children the key?

    Alex Richter, Zania Stamataki & , 15 May 2021, In: BMJ Paediatrics Open. 5, 1, e001063.

    Research output: Contribution to journalReview articlepeer-review

  6. Published
  7. Published
  8. E-pub ahead of print

    The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer

    Akshay Patel, Alex Richter, Mark Drayson & Gary Middleton, 4 Jan 2020, (E-pub ahead of print) In: Cancer Immunology Immunotherapy.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    The primary immunodeficiency disorders

    Adrian Shields & , 1 Oct 2017, In: Medicine. 45, 10, p. 597-604

    Research output: Contribution to journalArticlepeer-review

  10. Published
  11. Published
  12. Published

    The evolution of cellular deficiency in GATA2 mutation

    & 13 others, , Gideon Hirschfield, Alex Richter, , , , , , , , , & , 6 Feb 2014, In: Blood. 123, 6, p. 863-74 12 p.

    Research output: Contribution to journalArticlepeer-review

  13. Published

    The benefits of physical exercise for the health of the pancreatic β-cell: a review of the evidence

    Mark Drayson, , , Jonathan Barlow, Thomas Solomon & Parth Narendran, 1 Apr 2020, In: Experimental Physiology. 105, 4, p. 579-589 11 p.

    Research output: Contribution to journalReview articlepeer-review

  14. Published

    Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis

    Adrian Shields, , , , , , & , Feb 2015, In: Clinical and Experimental Immunology. 179, 2, p. 210-219 10 p.

    Research output: Contribution to journalArticlepeer-review

  15. Published
  16. Published

    Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

    Sylvie Freeman, , , , , , , , , , , & , 22 Oct 2019, In: Blood Advances. 3, 20, p. 3052-3061 10 p.

    Research output: Contribution to journalArticlepeer-review

  17. Published
  18. Published
  19. Published
  20. E-pub ahead of print

    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    8 Dec 2020, (E-pub ahead of print) In: The Lancet. 397, 10269, p. 99-111 13 p.

    Research output: Contribution to journalArticlepeer-review

  21. Published
  22. E-pub ahead of print
  23. Published

    Role of minimal (measurable) residual disease assessment in older patients with acute myeloid leukemia

    Sylvie Freeman & , 1 Jul 2018, In: Cancers. 10, 7, 15 p., 215.

    Research output: Contribution to journalReview articlepeer-review

  24. Published
  25. Published
  26. Published
  27. E-pub ahead of print

    Reply to G. Gui et al

    Aimee Jackson & Sylvie Freeman, 5 May 2021, (E-pub ahead of print) In: Journal of Clinical Oncology.

    Research output: Contribution to journalComment/debatepeer-review

  28. Published

    Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

    & 9 others, , , , , , , , & , 29 Jun 2021, In: Cell Reports. 35, 13, 24 p., 109292.

    Research output: Contribution to journalArticlepeer-review

  29. Published

    Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

    Mark Drayson, , , , Dickens Pratt, , , , , , , , Anna Whittaker, Peter Hawkey, & , Nov 2019, In: Health Technology Assessment. 23, 62, p. 1-94

    Research output: Contribution to journalArticlepeer-review

  30. Published

    Progenitor cells are mobilized by acute physiological stress but not beta-adrenergic receptor agonist infusion

    Graham Wallace, , Mark Drayson, , , , , & Jos Bosch, Oct 2015, In: Brain, Behaviour, and Immunity. 49, p. 49-53 5 p.

    Research output: Contribution to journalArticlepeer-review

  31. Published
  32. Published
  33. Published
  34. Published

    Morning vaccination enhances antibody response over afternoon vaccination: a cluster-randomised trial

    Joanna Long, Mark Drayson, Angela Taylor, Kai Toellner, Janet Lord & Anna Whittaker, 23 May 2016, In: Vaccine. 34, 24, p. 2679-2685 7 p.

    Research output: Contribution to journalArticlepeer-review

  35. Published

    Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    Robert Hills, Sylvie Freeman & 19 others, , Igor Novitzky Basso, , , , , , , , , , , , , , , , & , 27 Feb 2020, In: Blood. 135, 9, p. 680-688 9 p.

    Research output: Contribution to journalArticlepeer-review

  36. Published

    MRD evaluation of AML in clinical practice: are we there yet?

    Sylvie Freeman & , 6 Dec 2019, In: Hematology. 2019, 1, p. 557-569

    Research output: Contribution to journalArticlepeer-review

  37. Published
  38. Published
  39. Published
  40. Published
  41. Published
  42. E-pub ahead of print
  43. Published

    Induced mild systemic inflammation is associated with impaired ability to improve cognitive task performance by practice

    Jos Bosch, Chris Ring, Mark Drayson & , Mar 2015, In: Psychophysiology. 52, 3, p. 333-341 9 p.

    Research output: Contribution to journalArticlepeer-review

  44. E-pub ahead of print

    In-house age-specific reference ranges for free light chains measured on the SPAPlus® analyser

    Adrian Shields, , & , 18 Dec 2019, (E-pub ahead of print) In: Annals of Clinical Biochemistry.

    Research output: Contribution to journalArticlepeer-review

  45. Published
  46. E-pub ahead of print

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML).

    Sylvie Freeman & , Oct 2020, (E-pub ahead of print) In: British Journal of Haematology.

    Research output: Contribution to journalArticlepeer-review

  47. E-pub ahead of print

    How to establish an academic SARS-CoV-2 testing laboratory

    Alex Richter, , , , , , , , Thomas White, , Jeremy Mirza, & Alan McNally, 2 Nov 2020, (E-pub ahead of print) In: Nature Microbiology.

    Research output: Contribution to journalArticle

  48. Published
  49. Published
  50. Published

    Future developments: measurable residual disease

    Sylvie Freeman, May 2021, Acute Myeloid Leukemia. Röllig, C. & Ossenkoppele, G. J. (eds.). 1 ed. Springer, p. 317-337 21 p. (Hematologic Malignancies (HEMATOLOGIC)).

    Research output: Chapter in Book/Report/Conference proceedingChapter

Previous 1 2 Next